⚠ Evidence warning: Clinical trials or other evidence do not support the claim that Rhodiola helps altitude adaptation, cold tolerance, glycogen sparing and recovery between training sessions, or that it makes heavy exercise safer for people with hidden heart disease. This page keeps it as a report of what people, websites or other media say.
Rhodiola Rosea for Athletic Performance
The De Bock et al. 2004 trial of Rhodiola rosea in young healthy volunteers, published in the International Journal of Sport Nutrition and Exercise Metabolism, is the reference trial for Rhodiola as an acute ergogenic aid: 200 mg of an extract standardized to 3% rosavin and 1% salidroside, taken 60 minutes before exercise, lengthened time to exhaustion slightly (16.8 to 17.2 minutes) and raised peak oxygen uptake, while its other measures did not change. A later single-dose trial (Noreen 2013) reported a slightly lower heart rate during a warm-up and a lower rating of perceived exertion (RPE). Proposed mechanisms include lower blood lactate (seen after 4 weeks of daily use in one trial), fatty acid mobilization sparing muscle glycogen (seen in animal studies), reduced exercise-induced oxidative damage, and adrenal catecholamine moderation. The Soviet research program (Spasov, Krasik) originally developed Rhodiola as a fatigue-prophylaxis agent for military Special Forces operating in extreme cold and at high altitude, and a standardized Rhodiola extract was supplied to Soviet Olympic athletes through the 1970s and 1980s as a state-approved ergogenic. This deep-dive walks through the De Bock 2004 protocol in clinical detail, the lactate-threshold improvement evidence, the perceived-exertion reduction mechanism (likely central monoaminergic), the military fatigue-prophylaxis research, and the 60-minutes-before-exercise timing used in the trials.
Table of Contents
- Viking, Sherpa, and Soviet Athletic History
- The De Bock 2004 Endurance Trial
- Lactate Threshold Improvement
- Perceived Exertion Reduction
- Muscle Glycogen Sparing and Fatty Acid Mobilization
- Reduced Exercise-Induced Oxidative Damage
- Cardiovascular Efficiency and Heart Rate Response
- Military Fatigue Prophylaxis (Cadet Trial)
- Acute Pre-Exercise vs Chronic Daily Dosing
- The 60-Minutes-Before-Exercise Dosing Protocol
- Cautions and Drug Interactions
- Key Research Papers
- Connections
- Featured Videos
Viking, Sherpa, and Soviet Athletic History
The athletic-performance use of Rhodiola rosea predates modern sports nutrition by approximately a millennium. The traditional uses cluster around populations facing extreme physical demands under extreme environmental stress — cold, altitude, sustained exertion, and the combination of all three.
The Norse Vikings of the 8th-11th centuries reportedly brewed Rhodiola root as a tea consumed in quantity before long sea voyages and military engagements, and the herb is documented as part of the Viking-era pharmacopoeia in the historical sagas of Iceland and the Orkney Islands. The herb was credited with increasing physical strength, endurance, and the cold tolerance needed to survive the open-boat crossings of the North Atlantic.
The Sherpa and Tibetan populations of the high Himalayas have used Rhodiola for centuries as an altitude-adaptation aid. Tibetan medical texts describe the herb for «mountain sickness,» lung ailments, and the general debility of high-altitude living. The mechanism — improved oxygen utilization, enhanced erythropoiesis, and reduced hypothalamic-pituitary-adrenal-axis stress response — aligns with the hypoxia-adaptation requirements of populations living at 3,000-5,000 meters elevation. Modern preclinical work has confirmed that salidroside improves hypoxia tolerance in animal models, providing molecular support for the traditional use.
The Soviet athletic use program is the most extensively documented of the historical applications. Beginning in 1969 with formal Soviet Ministry of Health and Pharmacopoeia Commission authorization, standardized Rhodiola rosea extract was supplied to:
- Soviet Olympic athletes for general training support and competition preparation
- Soviet Special Forces (Spetsnaz) units operating in extreme cold (Arctic, high altitude, Siberian winter conditions)
- Soviet military pilots completing long-duration combat air patrol
- Soviet submarine crews during extended underwater deployments
- Soviet cosmonauts in the Salyut and later Mir space programs
- Polar expedition members
The Soviet ergogenic-aid program operated parallel to the better-known doping programs but with a different rationale — Rhodiola was classified as a legal natural adaptogen rather than a banned performance-enhancing drug, and its use continued openly through the 1970s and 1980s. Much of the Soviet-era performance data was published only in Russian-language journals and remained inaccessible to Western sports science until the 1990s.
The De Bock 2004 Endurance Trial
De Bock K, Eijnde BO, Ramaekers M, Hespel P (2004) at the Catholic University of Leuven in Belgium published the modern reference trial for acute Rhodiola supplementation, in the International Journal of Sport Nutrition and Exercise Metabolism. The trial design tested the acute (single-dose, pre-exercise) effect of Rhodiola on endurance exercise capacity in a population of recreationally active healthy young adults.
Trial details:
- Population: 24 young healthy volunteers (Phase I); 12 subjects in Phase II
- Design: randomized, double-blind, placebo-controlled, crossover — each subject completed one 2-day test session after Rhodiola and one after placebo, separated by a 5-day washout
- Dose: 200 mg of an extract containing 3% rosavin and 1% salidroside (plus 500 mg starch; the placebo was 700 mg starch) taken 1 hour before testing
- Tests: day 1 — speed of limb movement, hearing and visual reaction time, and sustained attention; day 2 — maximal knee-extension strength and an endurance exercise test to exhaustion
- Phase II: a double-blind, placebo-controlled study in which 12 subjects took 200 mg of Rhodiola or placebo every day for 4 weeks, with the same tests before and after
Results in the Rhodiola condition compared to placebo:
- Time to exhaustion: increased from 16.8 to 17.2 minutes (statistically significant)
- Peak oxygen uptake (VO2peak): increased from 50.9 to 52.9 ml per minute per kg of body weight; peak carbon dioxide output rose from 60.0 to 63.5
- Breathing volume (pulmonary ventilation): tended to rise (115.9 vs 124.8 litres per minute; not statistically significant)
- All other measures: unchanged, including strength, limb speed, reaction time and attention
- 4 weeks of daily use (Phase II): did not change any of the measures, and did not alter the response to a single dose
The absolute magnitude of the time-to-exhaustion improvement (0.4 minutes, from 16.8 to 17.2) is small in athletic terms but meaningful at the margins of competitive performance. The authors concluded that a single dose of Rhodiola can improve endurance exercise capacity in young healthy volunteers. Heart rate, blood lactate and perceived exertion were not among the reported findings of this trial; the heart-rate and perceived-exertion results come from later trials (see below).
Lactate Threshold Improvement
The lactate threshold is the exercise intensity at which blood lactate concentration begins to accumulate above baseline — the point at which anaerobic metabolism begins to substantially contribute to adenosine triphosphate (ATP) production and metabolic byproducts begin to limit sustainable exercise duration. The lactate threshold is one of the most physiologically meaningful determinants of endurance performance, more predictive than maximal oxygen uptake (VO2max) for the actual question of how long an athlete can sustain a given pace.
The De Bock 2004 trial did not report a change in blood lactate. In a 2010 trial of 14 trained male athletes, 4 weeks of daily Rhodiola lowered blood lactate and creatine kinase (a muscle-damage marker) after an exhaustion test compared with placebo, while maximum heart rate, Borg exertion score, maximal oxygen uptake and test duration were essentially unchanged (Parisi 2010). In a 2021 bench-press trial, blood lactate after exercise was higher with Rhodiola than with placebo (Williams 2021). Proposed mechanisms for a lactate effect include:
- Improved mitochondrial function — Rhodiola supports mitochondrial biogenesis and respiratory chain efficiency, allowing more adenosine triphosphate production via aerobic oxidation and less reliance on glycolytic fermentation
- Enhanced fatty acid oxidation — fatty acid beta-oxidation produces adenosine triphosphate without lactate as a byproduct, while glucose metabolism produces lactate; shifting substrate utilization toward fats reduces lactate accumulation
- Improved lactate clearance — both hepatic and cardiac lactate uptake and oxidation appear to improve with Rhodiola supplementation in animal studies
- AMP-activated protein kinase (AMPK) activation — AMP-activated protein kinase is the master regulator of cellular energy homeostasis, and Rhodiola compounds activate AMP-activated protein kinase in muscle tissue, promoting both glucose uptake and fatty acid oxidation
The clinical implication for endurance athletes is that Rhodiola may modestly improve sustainable race pace at the lactate-threshold-limited intensities that determine performance in events from 10K running to marathon to time-trial cycling to Olympic-distance triathlon. The effect size is modest (single-digit percent); a 2023 systematic review of 13 randomized trials described the results as heterogeneous, with unclear or high risk of bias in most of the studies (Sanz-Barrio 2023).
Perceived Exertion Reduction
The rating of perceived exertion (RPE) is the subjective measure of how hard an exercise effort feels to the athlete, typically measured on the Borg 6-20 scale or the modified Borg 0-10 scale. RPE is determined by both peripheral signals (lactate accumulation, muscle damage, glycogen depletion, body temperature) and central neurological factors (motivation, central fatigue, monoamine neurotransmitter tone, perceived effort versus available capacity).
Two small single-dose trials measured it. In Noreen 2013 (18 people, 3 mg per kg of body weight 1 hour before), a 6-mile cycling time trial took 25.4 minutes after Rhodiola versus 25.8 minutes after placebo, mean RPE on a 10-point scale was 6.0 versus 6.6, and heart rate during the standardized warm-up was 136 versus 140 beats per minute. In Duncan and Clarke 2014 (10 active men, 3 mg per kg, 30 minutes of cycling at 70% of VO2max), RPE was lower at 30 minutes, and arousal, pleasure and vigor were higher, while energy expenditure and fat and carbohydrate burning did not change. The 2023 systematic review found that single doses before exercise lowered RPE. Two interacting mechanisms are proposed:
- Peripheral mechanism: reduced lactate accumulation, reduced heart rate response, and reduced exercise-induced oxidative damage all produce less peripheral «distress signaling» from the working muscles to the brain. Less peripheral signal means lower subjective effort.
- Central mechanism: the monoamine-availability effect of Rhodiola (increased serotonin, dopamine, and norepinephrine availability through inhibition of the enzymes monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT)) plays into the central-governor model of exercise. Higher central monoamine tone is associated with greater pain tolerance, greater effort tolerance, and lower subjective effort at matched workload. The same mechanism that produces cognitive-performance preservation under stress also produces effort-tolerance during exhausting exercise.
The central component is the more interesting from a sports-science standpoint because it suggests that Rhodiola is not merely a peripheral metabolic enhancer like creatine or beta-alanine, but works at the level of the central nervous system's exercise governance. This positions Rhodiola somewhere between conventional supplements that affect muscle metabolism and pharmacological agents (caffeine, modafinil) that affect central drive — with the unique advantage of producing benefit without the «crash» associated with caffeine and without the side-effect profile of pharmaceutical stimulants.
Strength work can show a different pattern. In 10 resistance-trained men, 3 days of 1,500 mg a day of Rhodiola plus 500 mg 30 minutes before testing made bench-press repetitions faster (higher mean lifting velocity) but lowered the total number of repetitions to failure; blood lactate after exercise was higher, and norepinephrine (a stress hormone) was higher before exercise, than with placebo. The authors concluded that it may help explosive lifting but may impair upper-body strength-endurance (Williams 2021).
Muscle Glycogen Sparing and Fatty Acid Mobilization
Endurance exercise depletes muscle glycogen stores at a rate proportional to exercise intensity. Bonking — the catastrophic depletion of carbohydrate substrate during prolonged exercise — is one of the most consistent limiters of marathon, long-distance cycling, and triathlon performance. Any intervention that spares muscle glycogen by shifting substrate utilization toward fatty acid oxidation extends the duration of sustainable exercise before bonking.
In animal studies, Rhodiola supplementation has been reported to:
- Enhance fatty acid mobilization from adipose tissue stores
- Promote fatty acid transport into the mitochondria via increased carnitine palmitoyltransferase (CPT) activity
- Increase fatty acid oxidation rates in working muscle
- Spare muscle and liver glycogen at submaximal exercise intensities
- Enhance post-exercise glycogen resynthesis
In people, a shift toward fat burning has not been shown. In Duncan and Clarke 2014 (10 active men, a single dose of 3 mg per kg, 30 minutes of cycling at 70% of VO2max), there were no differences in energy expenditure or in carbohydrate or fat oxidation between Rhodiola and placebo. Parisi 2010 found lower plasma free fatty acids after 4 weeks of daily use in 14 trained men.
The metabolic shift seen in the animal work is similar in direction to the adaptations seen with chronic endurance training itself or with deliberate carbohydrate-restriction protocols. The practical implication is that Rhodiola may particularly benefit ultra-endurance athletes (marathon, ultramarathon, ironman triathlon, long bike races) who are limited primarily by glycogen depletion rather than by sprint capacity or maximal power output.
The post-exercise glycogen resynthesis enhancement is interesting because it suggests Rhodiola may also have value in recovery between training sessions, not only as a pre-exercise ergogenic. Athletes in multi-day stage races or in heavy training blocks might benefit from chronic Rhodiola dosing for the recovery effect in addition to acute pre-event dosing for the performance effect.
Reduced Exercise-Induced Oxidative Damage
Strenuous exercise — particularly novel exercise or training at the edge of capacity — produces substantial oxidative damage through the generation of reactive oxygen species (ROS) during mitochondrial respiration. While moderate reactive oxygen species production is part of the normal training stimulus that drives adaptation, excessive reactive oxygen species production from acute extreme exertion contributes to muscle damage, prolonged soreness, and impaired recovery.
Studies of Rhodiola in exercising humans and animals have documented:
- Reduced post-exercise creatine kinase elevation (marker of muscle membrane damage)
- Reduced post-exercise lactate dehydrogenase elevation (marker of muscle cell damage)
- Reduced post-exercise malondialdehyde (a marker of lipid peroxidation, indicating reduced oxidative damage)
- Increased post-exercise total antioxidant capacity
- Increased post-exercise superoxide dismutase and glutathione peroxidase activity (endogenous antioxidant enzyme systems)
- Reduced post-exercise delayed-onset muscle soreness (DOMS) ratings
The mechanism centers on salidroside's activation of the Nrf2/heme oxygenase-1 (HO-1) antioxidant defense pathway. Nrf2 (nuclear factor erythroid 2-related factor 2) is a master transcription factor that controls the expression of dozens of antioxidant enzymes including superoxide dismutase, catalase, glutathione peroxidase, and the glutathione-synthesis machinery. By upregulating the entire endogenous antioxidant response, Rhodiola provides broader protection than supplementing any single exogenous antioxidant vitamin (like high-dose vitamin C or vitamin E, which have actually been shown to blunt training adaptation in some studies).
The practical implication for athletes is that Rhodiola may particularly benefit recovery in heavy training blocks, eccentric-loading workouts (downhill running, heavy lifting), and in events with significant muscle damage (marathon, ultra-endurance, contact sports). The dose-timing question for recovery is different from the dose-timing question for acute performance — for recovery, daily chronic dosing matters more than acute pre-exercise dosing.
Cardiovascular Efficiency and Heart Rate Response
The De Bock 2004 trial did not report a heart-rate effect. In Noreen 2013, heart rate during a standardized 10-minute warm-up was 136 beats per minute after Rhodiola versus 140 after placebo, so the same warm-up work was done at a slightly lower heart rate. Duncan and Clarke 2014 recorded heart rate during 30 minutes of cycling and did not report a difference, and in Parisi 2010 maximum heart rate was essentially unchanged after 4 weeks of daily use. The 2023 systematic review described the trial results as heterogeneous.
Proposed mechanisms include:
- Reduced sympathetic outflow — Rhodiola moderates catecholamine release from the adrenal medulla during exercise, reducing the beta-adrenergic stimulation of the heart
- Reduced myocardial catecholamine concentration — the heart tissue itself shows lower local catecholamine concentration after Rhodiola, with reduced cyclic AMP elevation
- Improved cardiac contractile efficiency — preclinical evidence suggests improved myocardial oxygen utilization, allowing the same stroke volume at lower oxygen demand
- Improved peripheral oxygen extraction — better oxygen utilization at the muscle level means the cardiovascular system needs to deliver less oxygen for the same external work
For athletes who train by heart rate zones — the standard approach in endurance sports — this matters in a specific practical way. Where heart rate at a given workload is lower, as in the Noreen warm-up, the same heart rate zones correspond to slightly different absolute workloads. Athletes training at «Zone 2» (typically 70-80% of maximum heart rate) would then be doing slightly higher absolute power output at the same heart rate. Conversely, athletes targeting specific external workloads will see slightly lower heart rates at those workloads, which can be misleading when comparing training load before and after starting Rhodiola.
The cardioprotective effect also has implications for older athletes and those with cardiovascular risk factors. The reduced cardiac stress at matched workloads may make heavy exercise safer for individuals with subclinical coronary disease or cardiac arrhythmia susceptibility. The trials cited on this page enrolled healthy volunteers and athletes; none tested Rhodiola in people with established cardiovascular disease or alongside beta-blockers, angiotensin-converting enzyme inhibitors (ACE inhibitors), or other cardiac medications.
Military Fatigue Prophylaxis (Cadet Trial)
The Shevtsov 2003 military cadet trial discussed in the Cognitive Performance deep-dive also has direct implications for military fatigue prophylaxis in extended-operations contexts. The trial showed that a single dose of Rhodiola in 161 military cadets aged 19-21 produced significant improvements in:
- Capacity for mental work under fatigue and stress (an antifatigue index of 1.0385 and 1.0195 for the two doses versus 0.9046 for placebo, p < 0.001); physical work capacity was not tested, though pulse rate and blood pressure were measured
- Associative thinking under sleep deprivation
- Short-term memory under stress
- Calculation speed under time pressure
- Reaction time and audiovisual processing
The military fatigue-prophylaxis use case combines both the physical-performance dimension (sustained patrols, equipment-laden marching, combat operations in extreme environments) and the cognitive-performance dimension (situational awareness, communication, target identification, decision-making under stress). Rhodiola is unique among ergogenic aids in addressing both simultaneously, which is why the Soviet military programs prioritized it over single-target agents like amphetamine stimulants or pure-physiological substrate supplements.
Modern military medicine continues to study Rhodiola and related adaptogens for fatigue prophylaxis in special operations, with particular interest in:
- Cold-weather operations (Arctic, mountain warfare) — where the traditional altitude-and-cold adaptogen background of Rhodiola is directly relevant
- Submarine operations — sustained sleep restriction and circadian disruption
- Aviator fatigue management — long-duration combat air patrol and night operations
- Recovery from extreme physical training programs — selection courses, ranger school, dive training
The integrative-medicine version of military fatigue prophylaxis applies to civilian populations facing similar demands: emergency department physicians on overnight call, intensive care unit (ICU) nurses on twelve-hour rotating shifts, long-distance truck drivers, expedition climbers, and ultra-endurance athletes. The mechanism is the same and the dosing protocol is the same.
Acute Pre-Exercise vs Chronic Daily Dosing
A particularly important distinction in Rhodiola sports use is between acute pre-exercise dosing (single dose 60 minutes before a specific workout or event) and chronic daily dosing (200-400 mg/day taken every day for weeks or months). The two protocols target different physiological objectives and have different supporting evidence:
Acute pre-exercise dosing:
- Target: maximize performance for a specific event or workout
- Mechanism: rapid monoaminergic effect on perceived exertion, acute catecholamine moderation reducing heart rate response, acute fatty acid mobilization
- Evidence: De Bock 2004 (time to exhaustion 16.8 to 17.2 minutes), Noreen 2013 and Duncan and Clarke 2014
- Doses used in trials: 200 mg standardized extract 60 minutes before exercise (De Bock 2004); 3 mg per kg of body weight (Noreen 2013, 1 hour before; Duncan and Clarke 2014)
- Used for: time trials, races, time-limited testing, single high-intensity training sessions, competitions
Chronic daily dosing:
- Target: adaptive support during training blocks, recovery enhancement, sustained stress tolerance
- Mechanism: hypothalamic-pituitary-adrenal-axis modulation, sustained antioxidant defense upregulation via Nrf2/HO-1, sustained mitochondrial function support, training adaptation enhancement
- Evidence: mixed; the chronic-dosing trials for endurance performance per se are smaller and less consistent than the acute trials (in De Bock 2004, 4 weeks of 200 mg a day changed none of the measures), but the chronic protocol has clear support for the broader stress and recovery dimensions
- Amounts used in practice: 200-400 mg/day in divided morning doses, sustained over training cycles of 4-12 weeks
- Used for: heavy training blocks, multi-day stage races, military selection courses, ultra-endurance training, recovery from injury or illness
The two protocols are not mutually exclusive. Some endurance athletes in a heavy training block combine them: 200 mg in the morning every day for sustained support, plus another 200 mg 60 minutes before key workouts or races, 400 mg in total that day, which practitioners describe as within the usual range. This combination was not tested in the trials cited on this page.
A 2023 systematic review of 13 randomized trials (263 participants, 198 men and 65 women aged 18-65) found the results heterogeneous. A single dose before exercise improved endurance performance and lowered RPE; weeks of daily use improved short, all-out (anaerobic) exercise performance but not endurance performance, and may reduce muscle damage. Most of the trials had unclear or high risk of bias, and the authors called for more high-quality studies (Sanz-Barrio 2023).
The 60-Minutes-Before-Exercise Dosing Protocol
The 60-minute pre-exercise timing of the De Bock 2004 protocol is based on the pharmacokinetics of salidroside and rosavin in humans. Plasma concentration of salidroside peaks approximately 60-90 minutes after oral administration of a standardized extract on an empty stomach, with elimination half-life of approximately 5-6 hours. The 60-minute pre-exercise timing positions the peak plasma concentration during the exercise itself, when the monoaminergic and metabolic effects are most needed.
The protocol as used in the trial and in practice:
- Dose: 200 mg standardized extract (3% rosavins / 1% salidroside)
- Timing: 60 minutes before the start of exercise
- With or without food: usually taken on an empty stomach for maximum absorption (food, particularly fatty meals, reduces salidroside bioavailability by approximately 25%)
- Fluid: usually taken with a full glass of water
- Stimulant stacking: combining it with high-dose caffeine, pre-workout formulas containing yohimbine or dimethylhexylamine (DMHA), or prescription stimulants raises a concern — the combined activation can produce arrhythmia susceptibility and acute hypertension during exercise
- First-time use: athletes commonly try Rhodiola in training before using it on race day, to learn their individual tolerability and dose
For events lasting more than 2 hours, some athletes split the dose: 200 mg taken 60 minutes pre-exercise plus an additional 200 mg taken at the 90-minute mark of the exercise itself (which would peak at approximately the 150-minute mark, near the late-event fatigue window). This split-dose protocol has not been formally tested in trials but is used empirically by some endurance athletes; the total dose of 400 mg in a single training session stays within the safe range.
For high-altitude expeditions (mountaineering, ski touring, trekking at >3,000m elevation), practitioners describe chronic daily dosing in the 200-400 mg/day range starting 2-4 weeks before the trip as better suited than acute pre-event dosing — the altitude-adaptation mechanism is gradual rather than acute, and the goal is to support the body's natural acclimatization process rather than to push acute performance.
Cautions and Drug Interactions
- Sport doping status — Rhodiola rosea is NOT on the World Anti-Doping Agency (WADA) prohibited list and is permitted in competitive sport. Athletes subject to drug testing check their own governing body's rules, and some choose products with third-party tested-for-sport certification, because adulteration with banned substances has been documented in the broader supplement industry.
- Pre-workout stimulant stacking — combining Rhodiola with high-dose caffeine, yohimbine, DMHA, synephrine, or pre-workout formulas containing multiple stimulants raises a concern. The combined activation can produce hypertension, tachyarrhythmia, and rarely serious cardiac events during high-intensity exercise.
- Beta-blockers — for athletes on beta-blockers for hypertension, anxiety, or cardiac arrhythmia, the concern raised is that the catecholamine-moderating effect of Rhodiola may be additive with beta-blockade and produce excessive bradycardia (slow heart rate) or hypotension (low blood pressure) during exercise.
- Anticoagulants and other CYP2C9 drugs — for athletes on warfarin or direct oral anticoagulants (DOACs: apixaban, rivaroxaban), the concern raised is an increased bleeding tendency. In 13 healthy volunteers, 14 days of a commercial Rhodiola product lowered the activity of the liver enzyme CYP2C9 by 21%; this enzyme clears warfarin and phenytoin, drugs with a narrow margin between an effective and a toxic dose, so their blood levels could rise, and the authors judged the effect possibly clinically relevant for them. The other liver enzymes tested (CYP1A2, CYP2C19, CYP2D6 and CYP3A4) were not affected (Thu 2016). For warfarin, the international normalized ratio (INR) blood test measures how long blood takes to clot.
- Heart rate-based training — where Rhodiola lowers heart rate at a given workload (136 versus 140 beats per minute in the Noreen 2013 warm-up), heart rate zones set beforehand correspond to a slightly different workload, which can be misleading when comparing training load week-over-week.
- Hot-environment exercise — Rhodiola does not impair thermoregulation, but the catecholamine moderation may reduce the early-warning subjective effort signal that protects athletes from heat exhaustion; standard hydration and heat-acclimatization protocols remain the main protection against heat exhaustion.
- Cold-environment exercise — Rhodiola is traditionally credited with improving cold tolerance, in line with its Arctic-adaptation use; it does not replace appropriate cold-weather gear and protocol.
- Altitude — Rhodiola is traditionally used for altitude adaptation, taken daily before ascent; it does not replace staged acclimatization, and descent is the standard response to symptoms of acute mountain sickness.
- Concurrent selective serotonin reuptake inhibitor (SSRI)/serotonin-norepinephrine reuptake inhibitor (SNRI)/monoamine oxidase inhibitor (MAOI) therapy — the concern raised in the depression context applies in the athletic context too: the combination carries an additive serotonergic risk (too much serotonin activity).
For the broader athletic-supplement context, see our Ginseng page (a related adaptogen with endurance evidence), Schisandra page (often used in combination Soviet/Russian protocols with Rhodiola), and the Fatigue page for the broader fatigue-management context.
Key Research Papers
- De Bock K, Eijnde BO, Ramaekers M, Hespel P (2004). Acute Rhodiola rosea intake can improve endurance exercise performance. International Journal of Sport Nutrition and Exercise Metabolism, 14(3), 298-307. — PubMed PMID: 15256690
- Lu Y, Deng B, Xu L, Liu H, Song Y, Lin F (2022). Effects of Rhodiola rosea supplementation on exercise and sport: a systematic review. Frontiers in Nutrition, 9, 856287. — PubMed PMID: 35464040
- Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV (2000). A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine, 7(2), 85-89. — PubMed PMID: 10839209
- Shevtsov VA, Zholus BI, Shervarly VI, Vol'skij VB, Korovin YP, Khristich MP, Roslyakova NA, Wikman G (2003). A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine, 10(2-3), 95-105. — PubMed PMID: 12725561
- Noreen EE, Buckley JG, Lewis SL, Brandauer J, Stuempfle KJ (2013). The effects of an acute dose of Rhodiola rosea on endurance exercise performance. Journal of Strength and Conditioning Research, 27(3), 839-847. — PubMed PMID: 23443221
- Parisi A, Tranchita E, Duranti G, Ciminelli E, Quaranta F, Ceci R, Cerulli C, Borrione P, Sabatini S (2010). Effects of chronic Rhodiola rosea supplementation on sport performance and antioxidant capacity in trained male: preliminary results. Journal of Sports Medicine and Physical Fitness, 50(1), 57-63. — PubMed PMID: 20308973
- Skarpanska-Stejnborn A, Pilaczynska-Szczesniak L, Basta P, Deskur-Smielecka E (2009). The influence of supplementation with Rhodiola rosea L. extract on selected redox parameters in professional rowers. International Journal of Sport Nutrition and Exercise Metabolism, 19(2), 186-199. — PubMed PMID: 19478343
- Duncan MJ, Clarke ND (2014). The effect of acute Rhodiola rosea ingestion on exercise heart rate, substrate utilisation, mood state, and perceptions of exertion, arousal, and pleasure/displeasure in active men. Journal of Sports Medicine, 2014, 563043. — PubMed PMID: 26464892
- Jówko E, Sadowski J, Długołęcka B, Gierczuk D, Opaszowski B, Cieśliński I (2018). Effects of Rhodiola rosea supplementation on mental performance, physical capacity, and oxidative stress biomarkers in healthy men. Journal of Sport and Health Science, 7(4), 473-480. — PubMed PMID: 30450257
- Williams TD, Langley HN, Roberson CC, Rogers RR, Ballmann CG (2021). Effects of short-term Golden Root Extract (Rhodiola rosea) supplementation on resistance exercise performance. International Journal of Environmental Research and Public Health, 18(13), 6953. — PubMed PMID: 34209617
- Ballmann CG, Maze SB, Wells AC, Marshall MM, Rogers RR (2019). Effects of short-term Rhodiola rosea (Golden Root Extract) supplementation on anaerobic exercise performance. Journal of Sports Sciences, 37(9), 998-1003. — PubMed PMID: 30371146
- Walpurgis K, Thomas A, Geyer H, Mareck U, Thevis M (2020). Dietary supplement and food contaminations and their implications for doping controls. Foods, 9(8), 1012. (Doping-control context) — PubMed PMID: 32727139
- Panossian A, Wagner H (2005). Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration. Phytotherapy Research, 19(10), 819-838. — PubMed PMID: 16261511
- Sanz-Barrio PM, Noreen EE, Gilsanz-Estebaranz L, Lorenzo-Calvo J, Martínez-Ferrán M, Pareja-Galeano H (2023). Rhodiola rosea supplementation on sports performance: a systematic review of randomized controlled trials. Phytotherapy Research, 37(10), 4414-4428. — PubMed PMID: 37495266
- Thu OK, Spigset O, Nilsen OG, Hellum B (2016). Effect of commercial Rhodiola rosea on CYP enzyme activity in humans. European Journal of Clinical Pharmacology, 72(3), 295-300. — PubMed PMID: 26613955
PubMed Topic Searches
Connections
- All Herbs
- Rhodiola Rosea Overview
- Rhodiola Benefits Hub
- Rhodiola for Stress & Fatigue
- Rhodiola for Cognitive Performance
- Rhodiola for Depression
- Ginseng (Endurance Adaptogen)
- Schisandra (Co-Adaptogen)
- Ashwagandha (Strength & Recovery)
- Holy Basil (Adaptogen)
- Fatigue
- Burnout
- Stress Management
- Magnesium (Athletic Cofactor)
- Cortisol Test
- History